Empowering Communities: Portable & Rapid AI Diagnostic Solutions For All
SolutionDx™ Inc. is a diagnostics platform company, leveraging the power of Artificial Intelligence (AI) and Machine Learning to provide superior Point-of-Care (POC) diagnostic solutions for everyone.
We are committed to developing more accurate rapid diagnostic tools and improving access to healthcare via remote testing and equipment-free diagnostic triage.
Our first line of products is composed of triage tests targeting the world leading infectious diseases: Tuberculosis, HIV and COVID-19.
Our Mission
-
Bringing testing to the patient (as opposed to shipping samples to centralized labs) provides faster results, improves access to care, uses simpler procedures, and cost less.
-
Today, testing needs to combine high sensitivity, connectivity, easy deployment, less dependence to laboratory systems, and cost effectiveness for global outreach.
-
Better disease prevention controls demand fast data reporting, secured data aggregation, resource management, geolocation for bio-awareness and customized solutions.
Our Platform
Find™: The Test Card
A proprietary microfluidic design allows the sample to form a reaction pattern that is later recognized and analyzed by an image processing algorithm.
Xplora™: The Analysis
A smartphone-operated Machine Learning Image Processing algorithm analyses the reaction pattern and provides an unbiased diagnostic in 15 minutes.
Dxter™: The Data Analytics
Results and geolocations are reported in real-time via a secured cloud-based server and aggregated into the Dxter™ Enterprise Solution platform.
Featured Products
Tuberculosis (TB) continues to be the leading infectious disease killer in the World with approximately 25% of the world population infected with TB and 10 million active cases. More than 40% of active TB cases are undiagnosed mainly due to poor access to diagnostic solutions. Today, diagnostic of tuberculosis remains a major challenge with either poor sensitivity tests, or expensive assays using centralized equipment.
Find™ TB was designed as a high-sensitivity triage test incorporating three different TB targets in a single test. Integrated with the Xplora™ smartphone-operated AI algorithm analysis tools, results are provided in 15 min and securely centralized in Dxter™.
Because Find™ TB is portable, connected and does not require any equipment, it offers a superior Point-of-Care diagnostic solution that can reach remote areas, especially in high TB burden countries.
Find™ TB
TB touch about 25% of the World population
HIV (human immunodeficiency virus) weakens the immune system, increasing the risk of tuberculosis infection in HIV patients. With over 40 million people living with HIV globally, and with HIV patients having a 18-fold greater risk of developing active TB, it is critical to integrate TB screening with HIV.
Find™ TB+HIV leverages the multiplexing capability of the platform to combine HIV with TB testing in a single card.
This test represents a unique solution that is simple to implement and streamlines testing solutions for population at risk.
